apl. Prof. Dr. Peter Goebell

Medizinische Fakultät Urologische Klinik

A randomised phase II study of Nivolumab plus Ipilimumab versus Standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST) (2018) Ahrens M, Scheich S, Goekbuget N, Boleti E, Gruenwald V, Escudier B, Goebell P, et al. Conference contribution Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL (2018) Boegemann M, Bedke J, Schostak M, Welslau M, Hering-Schubert C, Wolf T, Schleicher J, et al. Conference contribution Follow-up of bladder cancer. The right examinations at the right time (2018) Olbert P, Goebell P, Hegele A Journal article Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars series (2018) Black PC, Goebell P, Kamat AM, Nawroth R, Schmitz-Draeger BJ Journal article, Editorial Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer (2018) Schmidkonz C, Cordes M, Beck M, Goetz TI, Schmidt D, Prante O, Bäuerle T, et al. Journal article ATLAS: a phase 2, open-label study of rucaparib in patients with locally advanced (unresectable) or metastatic urothelial carcinoma (2018) Feyerabend S, Boegemann M, Goebell P, Stoeckle M, Nepert D, Wride K, Thomas D, et al. Conference contribution Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma - Analyses From the German Clinical RCC-Registry (2018) Goebell P, Staehler M, Mueller L, Nusch A, Scheffler M, Sauer A, Von Verschuer U, et al. Journal article Advanced Prostate Cancer Consensus Conference 2017. Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts (2018) Schostak M, Koenig F, Boegemann M, Goebell P, Hammerer P, Machtens S, Schwentner C, et al. Journal article An Essay on Health Services Research - Contributions from the Urology (2018) Goebell P Journal article, Editorial Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry (2018) Goebell P, Mueller L, Huebner A, Harich HD, Boller E, Koska M, Jaenicke M, Marschner N Journal article